Advertisement
United Therapeutics Corporation

United Therapeutics Corporation (UTHR) Stock Overview

Explore United Therapeutics Corporation’s financial performance, market position, analyst ratings, and future outlook.

UTHR●NASDAQ
HealthcareBiotechnology
$547.69
$1.78(0.32%)
U.S. Market opens in 16h 8m
Advertisement

United Therapeutics Corporation (UTHR)

Meyka AI Score

Z

Key Financials

Market Cap23.2B
P/E Ratio18.54
EPS (TTM)$27.05
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$512.85
3 Months$429.99
1 Year Target$457.60

UTHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of United Therapeutics Corporation (UTHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $457.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.54 and a market capitalization of 23.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.32%
5-Day Change
-2.73%
1-Month Change
-5.77%
3-Month Change
11.73%
6-Month Change
13.14%
Year-to-Date (YTD) Change
12.40%
1-Year Change
69.06%
3-Year Change
150.22%
5-Year Change
211.28%
All-Time (Max) Change
8887.73%

Contact Information

https://www.unither.com
301 608 9292
1040 Spring Street, Silver Spring, MD, 20910

Company Facts

1,305 Employees
IPO DateJun 17, 1999
CountryUS
Actively Trading

Frequently Asked Questions